[HTML][HTML] Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review
MM Sampaio, MLC Santos, HS Marques… - World journal of …, 2021 - ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm and was the first
neoplastic disease associated with a well-defined genotypic anomaly―the presence of the …
neoplastic disease associated with a well-defined genotypic anomaly―the presence of the …
miRNAs in chronic myeloid leukemia: small molecules, essential function
Z Litwińska, B Machaliński - Leukemia & Lymphoma, 2017 - Taylor & Francis
Chronic myeloid leukemia (CML) is a myeloproliferative disorder associated with clonal
expansion of cancerous bone marrow stem cells. Tyrosine kinase inhibitors (TKIs) targeting …
expansion of cancerous bone marrow stem cells. Tyrosine kinase inhibitors (TKIs) targeting …
[图书][B] Биопсии костного мозга: Монография
ЮА Криволапов - 2014 - books.google.com
В руководстве изложены основные сведения о нормальном гистологическом строении
костного мозга, проявлениях типовых патологических процессов, содержится …
костного мозга, проявлениях типовых патологических процессов, содержится …
[PDF][PDF] Synergistic effect of ponatinib and epigallocatechin-3-gallate induces apoptosis in chronic myeloid leukemia cells through altering expressions of cell cycle …
Purpose: Ponatinib (P) has been used for the treatment of chronic myeloid leukemia (CML)
and it is known that inhibition of BCR-ABL fusion protein by ponatinib induces apoptosis of …
and it is known that inhibition of BCR-ABL fusion protein by ponatinib induces apoptosis of …
[HTML][HTML] Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
Chronic myelogenous leukemia (CML) is a malignancy of the myeloid cell lineage
characterized by a recurrent chromosomal abnormality: the Philadelphia chromosome …
characterized by a recurrent chromosomal abnormality: the Philadelphia chromosome …
荧光原位杂交在慢性粒细胞白血病细胞BCR/ABL 融合基因检测中的应用及其意义
张济， 李君君， 颜家运， 邹礼衡， 刘静 - 实用医学杂志, 2012 - cqvip.com
目的: 探讨荧光原位杂交(FISH) 技术检测慢性粒细胞白血病(CML) 骨髓和外周血细胞的BCR/
ABL 融合基因的临床价值. 方法: 应用FISH 对正常对照组及CML 患者骨髓和外周血细胞BCR …
ABL 融合基因的临床价值. 方法: 应用FISH 对正常对照组及CML 患者骨髓和外周血细胞BCR …
一例合并t (9; 22; 16)(q34; q11; p13) 的慢性髓细胞白血病
许晓峰， 张学进 - 中华医学遗传学杂志, 2013 - cqvip.com
一例合并t(9;22;16)(q34;q11;p13)的慢性髓细胞白血病-[维普官方网站]-www.cqvip.com-维普网
我的维普 购物车 充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线 …
我的维普 购物车 充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线 …
[HTML][HTML] Recurrent chronic myeloid leukemia with t (9; 22; 16)(q34; q11; p13) treated by nilotinib: A case report
Y Shu, W Yang, X Zhang, X Xu - Medicine, 2018 - journals.lww.com
Abstract Rationale: Variant Philadelphia chromosome translocations involving
chromosomes other than chromosomes 9 and 22 have been reported in 5% to 10% of …
chromosomes other than chromosomes 9 and 22 have been reported in 5% to 10% of …
慢性粒细胞白血病向T 细胞淋巴瘤急变1 例
何斌， 孙梅， 顾健 - 实用临床医药杂志, 2016 - cqvip.com
1 临床资料患者, 男, 25 岁, 因" 确诊慢性粒细胞白血病(慢性期) 42 个月, 颈部包块1 月" 于2013
年04 月06 日入院. 2009 年10 月因" 乏力, 消瘦" 在苏州大学附属第一医院就诊 …
年04 月06 日入院. 2009 年10 月因" 乏力, 消瘦" 在苏州大学附属第一医院就诊 …
Cytogenetic analysis of patients with hematological malignancies
With this study, we aim to summarize and assess the activity and performance of the
Cytogenetic sector of the Laboratory of Medical Genetics—Varna, regarding the …
Cytogenetic sector of the Laboratory of Medical Genetics—Varna, regarding the …